Market Size of India Drug Delivery Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 5.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
India Drug Delivery Devices Market Analysis
The India Drug Delivery Devices Market is poised at a CAGR of nearly 5.5% during the forecast period (2022-2027).
COVID-19 has significantly impacted the Indian drug delivery devices market during the pandemic due to the shortage of drug delivery devices. For Instance, in September 2022, Bharat Biotech has conducted the product development related to pre-clinical safety evaluation, the large-scale manufacturing scale-up, the formulation, the delivery-device development, and human clinical trials and concluded that the intranasal vaccine will make it easier to deploy in mass immunisation campaigns with an easy-to-administer formulation and delivery device. Such developments are expected to rise in adoption of drug delivery devices in the administration of market growth, driving the market growth in India.
India has the second-largest population in the world according to OECD data. With the increasing population, the demand for better healthcare facilities has also increased. Newer and more efficient ways of drug delivery devices have been positively affected by this demand and hence this market is flourishing in India.
The factors driving the market growth in India include, rising prevalence of chronic diseases, rising technological advancements, innovative strategies adopted by the key market players, among others. It is not just the growing population, but also the increasing prevalence of chronic diseases that have caused a burden on the Indian population. According to International Diabetes Federation report published in 2021, the estimatated number of diabetes patients in 2021 in thousands were 74,194.7 and the number is expected to reach 92,973.7 by 2030. This has proven to be the major factor for the ease in demand for drug delivery devices for the delivery of insulin. Other factors like technological advancements in the field of drug delivery and demand for controlled release drugs have also affected this market positively.
According to the study titled 'Prevalence and Potential Determinants of Chronic Disease Among Elderly in India: Rural-Urban Perspectives' published in March 2022, in India, about 21% of the elderly population reportedly have at least one chronic disease. 17%elderly in rural areas and 29% in urban areas suffer from a chronic disease. Hypertension and diabetes account for about 68% of all chronic diseases.
In addition, in August 2021, Berry Global Group is planning to construct second manufacturing plant and a worldwide centre of excellence for healthcare in Bangalore, India. According to plans released by Berry, it wants to concentrate on its current position in inhalation devices, including models with digital capabilities and the next generation of injectable devices. Such initiatives will lead to increase manufacturing of drug delivery devices, thereby expected to rise in adoption, driving the market growth.
However, an increase in the risk of infections and side effects from these devices and stringent regulatory guidelines for the approval of drug delivery devices have been restraining the growth of this market.
India Drug Delivery Devices Industry Segmentation
As per the scope, drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. These devices are used as part of medical treatments. The India Drug Delivery Devices Market is segmented by Route of Administration (Injectable, Topical, Ocular and Others), and Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, Others). The report offers the value (in USD million) for the above segments.
| By Route of Administration | |
| Injectable | |
| Topical | |
| Ocular | |
| Others |
| By Application | |
| Cancer | |
| Cardiovascular | |
| Diabetes | |
| Infectious diseases | |
| Others |
| By End Users | |
| Hospitals | |
| Ambulatory Surgical Centers | |
| Others |
India Drug Delivery Devices Market Size Summary
The India Drug Delivery Devices Market is experiencing significant growth, driven by a combination of factors including the rising prevalence of chronic diseases, technological advancements, and innovative strategies by key market players. The demand for efficient healthcare solutions is increasing, fueled by India's large and growing population. This has led to a flourishing market for drug delivery devices, which are essential for the administration of treatments, particularly for chronic conditions such as diabetes and hypertension. The market is also witnessing advancements in drug delivery technologies, such as intranasal vaccines and inhalation devices, which are expected to enhance the ease of administration and improve patient compliance. However, challenges such as the risk of infections, side effects, and stringent regulatory guidelines continue to pose obstacles to market growth.
The market is moderately competitive, with both international and local players contributing to its dynamics. Global pharmaceutical companies are increasingly entering the Indian market, attracted by the growing demand for healthcare solutions. Domestic manufacturers are also establishing themselves as key players, further intensifying competition. The market is seeing a rise in the adoption of topical drug delivery systems, driven by their benefits such as noninvasive delivery and ease of use. The development of advanced transdermal patches and time-controlled drug delivery systems is expected to further propel the market. Notable companies in the market include Drägerwerk AG & Co. KGaA, B. Braun SE, Koninklijke Philips N.V., Medtronic Plc, and GlaxoSmithKline, among others, who are actively expanding their operations and product offerings in India.
India Drug Delivery Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Chronic Diseases
-
1.2.2 Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 Risk of Needlestick Injuries
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Route of Administration
-
2.1.1 Injectable
-
2.1.2 Topical
-
2.1.3 Ocular
-
2.1.4 Others
-
-
2.2 By Application
-
2.2.1 Cancer
-
2.2.2 Cardiovascular
-
2.2.3 Diabetes
-
2.2.4 Infectious diseases
-
2.2.5 Others
-
-
2.3 By End Users
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Others
-
-
India Drug Delivery Devices Market Size FAQs
What is the current India Drug Delivery Devices Market size?
The India Drug Delivery Devices Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)
Who are the key players in India Drug Delivery Devices Market?
Drägerwerk AG & Co. KGaA, Koninklijke Philips N.V., B. Braun SE, Medtronic Plc and Sanofi are the major companies operating in the India Drug Delivery Devices Market.
